Thalidomine USP26 en es it fr

Thalidomine USP26 Brand names, Thalidomine USP26 Analogs

Thalidomine USP26 Brand Names Mixture

  • No information avaliable

Thalidomine USP26 Chemical_Formula

C16H13Cl3N2OS

Thalidomine USP26 RX_link

http://www.rxlist.com/cgi/generic3/tioconaz.htm

Thalidomine USP26 fda sheet

Thalidomine_USP26 FDA

Thalidomine USP26 msds (material safety sheet)

Thalidomine USP26 Synthesis Reference

No information avaliable

Thalidomine USP26 Molecular Weight

387.711 g/mol

Thalidomine USP26 Melting Point

No information avaliable

Thalidomine USP26 H2O Solubility

No information avaliable

Thalidomine USP26 State

Solid

Thalidomine USP26 LogP

4.971

Thalidomine USP26 Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Thalidomine USP26 Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Thalidomine USP26 Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Thalidomine USP26 Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Thalidomine USP26 side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Thalidomine USP26 Patient Information

Thalidomine USP26 Organisms Affected

Yeast and other fungi